Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Warning LetterClosed

United StatesIssued Feb 21, 2018

Letter not published by FDA

Source: FDA warning letter records. FDA has not published the text of this letter.

Violations0

Issue DateFeb 21, 2018

Product TypeOther

StatusClosed

Letter Details

Firm: Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical
Location: United States
FEI Number: N/A
Country: United States
Issue Date: February 21, 2018
Issuing Office: N/A
Product Type: Other
Status: Closed

Summary

Based on limited metadata, Fusion IV Pharmaceuticals, Inc. (operating as Axia Pharmaceutical) received an FDA Warning Letter on February 21, 2018, regarding an unspecified product category. Without access to the full letter text or specific subject line, the precise nature of the violations cannot be determined from the available information. The warning was issued by the FDA, though the specific issuing office is not identified in this metadata summary.

Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical FDA Warning Letter, February 21, 2018